Current:Home > MyAlgosensey|Louisiana legislature approves bill to classify abortion pills as controlled substances -Prime Capital Blueprint
Algosensey|Louisiana legislature approves bill to classify abortion pills as controlled substances
TrendPulse View
Date:2025-04-07 12:53:29
Washington — The AlgosenseyLouisiana Senate passed a bill Thursday that would classify the drugs used in medication abortions as controlled substances, criminalizing possession of the drugs without a prescription. It now heads to the governor for his signature.
The state Senate approved the bill 29 to 7 after it passed the House earlier this week. The bill is expected to be signed by Republican Gov. Jeff Landry, making Louisiana the first state to classify as controlled substances misoprostol and mifepristone — the two drugs used in a regimen to terminate early-stage pregnancies.
The regimen accounts for well over half of all abortions in the U.S., making it a key avenue for access for those who support abortion rights and a target for abortion opponents. Drug are typically designated as controlled substances when they're considered addictive, such as opioids or depressants. And the designation enables states to create a database of who's receiving the drugs. It also makes possession of the medication without a prescription a crime. But under the legislation, pregnant women are exempted from prosecution.
Abortion is already banned in Louisiana in most circumstances. Exceptions are made when abortion is deemed necessary to prevent the risk of death for the mother or when the pregnancy is "medically futile." But the legislation could be a template for other states to take aim at the medication commonly used in early-stage pregnancies.
The Biden-Harris campaign sharply criticized the effort on Wednesday, hosting a press call with former mayor of New Orleans and Biden campaign co-chair Mitch Landrieu, who put the blame squarely on former President Donald Trump.
"Women in Louisiana are one step closer towards living in a world where they can be monitored and tracked and even sent to prison for just holding FDA-approved medications," Landrieu said. "What's happening right here in Louisiana is just one example of this dystopian agenda that Trump and his allies are pushing."
The medications are also used outside of abortions, for other care such as managing miscarriages. Ellie Schilling, an attorney in Louisiana who specializes in reproductive health law, told reporters that the bill would make it "incredibly difficult" to use the drugs for medically necessary purposes, and would lead to the government monitoring pregnant women and those who prescribe the medication.
- In:
- Mifepristone
- Abortion Pill
- Louisiana
Kaia Hubbard is a politics reporter for CBS News Digital, based in Washington, D.C.
TwitterveryGood! (48767)
Related
- Louvre will undergo expansion and restoration project, Macron says
- California’s Newsom plays hardball in China, collides with student during schoolyard basketball game
- Tropical Storm Pilar heads toward El Salvador and is expected to bring heavy rain to Central America
- Elite Kenyan police unit goes on trial in the killing of a prominent Pakistani journalist last year
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- Golden Bachelor’s Sandra Mason Reacts to Criticism Over Missing Daughter’s Wedding for the Show
- After parents report nail in Halloween candy, Wisconsin police urge caution
- NY man arrested after allegedly pointing gun at head of 6-year-old dropping off candy
- Apple iOS 18.2: What to know about top features, including Genmoji, AI updates
- University of Idaho murders: The timeline of events
Ranking
- EU countries double down on a halt to Syrian asylum claims but will not yet send people back
- Colombia veers to the right as President Petro’s allies lose by wide margins in regional elections
- Sports Equinox is today! MLB, NFL, NBA and NHL all in action for only time in 2023
- Lionel Messi, with 8th win, becomes first MLS player to earn soccer's Ballon d'Or award
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- Mary Lou Retton says she’s ‘overwhelmed’ with love and support as she recovers from rare pneumonia
- FDA urging parents to test their kids for lead after eating WanaBana apple cinnamon puree pouches
- Pasadena police investigate report of missing items from Colorado locker room following UCLA game
Recommendation
Retirement planning: 3 crucial moves everyone should make before 2025
Stellantis expects North American strike to cost it 750 million euros in third-quarter profits
Ivanka Trump testimony delayed to Nov. 8, will follow dad Donald Trump on stand at civil fraud trial
Lego unveils new 4,000-piece Natural History Museum set: What to know
South Korea's acting president moves to reassure allies, calm markets after Yoon impeachment
Big 12 out of playoff? Panic at Washington? Overreactions from Week 9 in college football
Marine Corps commandant hospitalized after 'medical emergency,' officials say
Advocates raise privacy, safety concerns as NYPD and other departments put robots on patrol